| Website | innavirvax.fr |
| Category | BioTech |
| Phone | +33 (0)1 80 85 60 83 |
| contact@innavirva... | |
| Employees |
| TOTAL | $4.9M |
| FUNDING TOTAL | $4.9M |
| Series B, 2/12 | $4.9M |
InnaVirVax is a privately-owned biopharmaceutical company dedicated to the development of a cutting edge discovery in the field of therapy/prevention and prognostic of AIDS and HIV infection, other infectious diseases, and new cancer therapies.
